← Patent-cliff monitor Loss of exclusivity July 2038 latest FDA-listed patent expiry
Drug detail Brand name TURALIO Active ingredient PEXIDARTINIB HYDROCHLORIDE Strength EQ 200MG BASE Dosage form CAPSULE Route ORAL Modality Small molecule FDA approval August 2019 Marketing status DISCN
Listed patents Patent Expires Type 10961240 July 2038 use U-2606 10435404 July 2038 product 10941142 July 2038 product 9802932 May 2036 substance 10189833 May 2036 use U-2606 10730876 May 2036 substance 9358235 June 2033 use U-2606 7893075 May 2033 substance 8461169 April 2028 use U-2606 8404700 November 2027 substance 8722702 November 2027 substance 9169250 November 2027 substance
Regulatory exclusivity Code Expires ODE-250 August 2026
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.